Nintedanib plus letrozole in early breast cancer: A phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition

  1. Quintela-Fandino, M.
  2. Apala, J.V.
  3. Malon, D.
  4. Mouron, S.
  5. Hornedo, J.
  6. Gonzalez-Cortijo, L.
  7. Colomer, R.
  8. Guerra, J.
Journal:
Breast Cancer Research

ISSN: 1465-542X,  1465-5411

Year of publication: 2019

Volume: 21

Issue: 1

Type: Article

DOI: 10.1186/S13058-019-1152-X GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus